The life sciences sector is at a crossroads as the FDA updates quality management standards. AI is now expected, and the FDA’s January 2025 draft guidance outlines its evaluation and implementation. Successful adoption depends on three key questions.
Safe and Sane: Understanding the FDA’s Risk-Based Approach to AI
Related Posts
Why It’s Time to Move Quality Data from Files to Databases
Explore five key advantages of transitioning from traditional file-based storage to centralized database systems, and why this shift…
InnovMetric Extends PolyWorks Through Collaboration with High QA, AutoForm, Duwe-3d
InnovMetric announced a new PolyWorks® Digital Thread partnership program.
Industry 4.0 for Apprenticeships, Degree Programs
Global challenges and industrial competitiveness are having an impact on the training and continuous education of skilled workers…